VolitionRx Limited (VNRX) News
Follow VolitionRx Limited (VNRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
VolitionRx Announces $500,000 Cash Prepayment on Convertible Note
VolitionRx Limited announced a $500,000 partial prepayment of a convertible note in cash.
EQUITY | Oct 27, 2026, 12:20 PM UTC
L
VNRX - VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
VNRX - VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
EQUITY | Sep 17, 2026, 01:18 PM UTC
L
VNRX - VolitionRx Participates in Launch of DETECSEPS Program in France
VNRX - VolitionRx Participates in Launch of DETECSEPS Program in France
NEWS | Sep 17, 2026, 12:17 PM UTC
L
VolitionRx pre-pays $422k of 2025 convertible note; $2.04M Lind note remains outstanding
VolitionRx prepaid approximately $422,000 to retire its 2025 senior secured convertible note, eliminating that instrument and reducing potential equity overhang.Key Highlights:Original SEC Filing: VOLITIONRX LTD [ VNRX ]
REGULATION | Sep 14, 2026, 09:15 PM UTC
L
VNRX: Strong IP, new products, and global partnerships drive licensing and clinical adoption in 2026
Recent milestones include a $5M milestone opportunity, new product launches, and expansion into non-sepsis disease areas. The company leverages a strong IP portfolio, asset-light model, and global partnerships, with mult
EQUITY | Sep 10, 2026, 12:35 PM UTC
L
VNRX - Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
VNRX - Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
EQUITY | Sep 10, 2026, 12:17 PM UTC
M
Lagoda-backed holder files Schedule 13D after 7.4% VolitionRx stake
Fatima Dickey, via Lagoda Investment Management, disclosed a 7.4% stake in VolitionRx. The holder switched from a passive Schedule 13G to an active Schedule 13D filed September 4, 2026.
EQUITY | Sep 04, 2026, 09:37 PM UTC
L
Volitionrx files preliminary prospectus for 10,006,360 common shares
Volitionrx filed a preliminary prospectus for 10,006,360 shares of common stock to be offered by a selling stockholder.
REGULATION | Aug 28, 2026, 08:33 PM UTC
L
VNRX - VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Click For Releas
VNRX - VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
EQUITY | Aug 26, 2026, 01:17 PM UTC
L
Volition announces clinical validation for Nu.Q NETs biomarker in sepsis
Volition (VNRX) said clinical validation of its Nu.Q NETs biomarker in sepsis has been announced.
EQUITY | Aug 26, 2026, 12:17 PM UTC
L
VolitionRx reports Q2 2026 results and provides business update
VolitionRx Limited announces its second quarter 2026 financial results and a business update for VNRX, with no additional figures provided in the feed.
EARNINGS | Aug 13, 2026, 08:10 PM UTC
L
VNRX - Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
VNRX - Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
EQUITY | Aug 12, 2026, 12:17 PM UTC
L
VNRX - VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
VNRX - VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
EARNINGS | Aug 11, 2026, 08:10 PM UTC
M
Volition Publishes Paper On Capture-Seq Liquid Biopsy
Volition publishes peer-reviewed paper on new liquid biopsy tech
EQUITY | Aug 05, 2026, 12:48 PM UTC
H
Volition Advances Nu.Q Platform
Volition advances platform towards commercialization
EQUITY | Jul 30, 2026, 12:18 PM UTC
L
VolitionRx registers to sell 3.31M shares of common stock for holders
VolitionRx registers to sell 3.31M shares of common stock for holders
EQUITY | Jul 10, 2026, 09:31 PM UTC